Medtronic Diabetes Unit MiniMed Seeks $784 Million in US IPO

MiniMed Group Inc., a diabetes management firm that will be separated from health-care giant Medtronic Plc, is seeking to raise as much as $784 million in an initial public offering.

The Northridge, California-based firm plans to market 28 million shares for $25 to $28 each, according to its filing Tuesday with the US Securities and Exchange Commission. The IPO is expected to price March 5, an investor presentation shows.